“…8,10,13,14 Very recently, NpAS active site was deeply reshaped to adapt the enzyme to the glucosylation of unnatural and slightly protected disaccharides entering in a programmed chemo-enzymatic pathway designed for bacterial antigen synthesis. 15 Using a computer-aided approach, semi-rational libraries, totaling about 2.7 3 10 4 variants and targeting 23 amino acid positions of subsites 11 and 12 in the active site first shell, were designed. Upon library construction, the mutants were screened, first, on sucrose activity and, next, on their ability to catalyze the glucosylation of the target acceptor, a partially protected b-linked disaccharide, the allyl (2-deoxy-2-trichloroacetamido-b-D-glucopyranosyl)-(1!2)-a-L-rhamnopyranoside.…”